Pulsenmore Ltd. Ordinary Shares (PLSM) - Total Assets
Based on the latest financial reports, Pulsenmore Ltd. Ordinary Shares (PLSM) holds total assets worth $101.85 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check total reinvestment intensity of Pulsenmore Ltd. Ordinary Shares to assess the company's total reinvestment commitment from operating cash flow.
Pulsenmore Ltd. Ordinary Shares - Total Assets Trend (2019–2025)
This chart illustrates how Pulsenmore Ltd. Ordinary Shares's total assets have evolved over time, based on quarterly financial data. Check PLSM tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Pulsenmore Ltd. Ordinary Shares - Asset Composition Analysis
Current Asset Composition (December 2025)
Pulsenmore Ltd. Ordinary Shares's total assets of $101.85 Million consist of 79.9% current assets and 20.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 21.2% |
| Accounts Receivable | $4.89 Million | 4.8% |
| Inventory | $6.59 Million | 6.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how Pulsenmore Ltd. Ordinary Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Pulsenmore Ltd. Ordinary Shares (PLSM) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Pulsenmore Ltd. Ordinary Shares's current assets represent 79.9% of total assets in 2025, a decrease from 84.7% in 2019.
- Cash Position: Cash and equivalents constituted 21.2% of total assets in 2025, down from 77.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 6.5% of total assets.
Pulsenmore Ltd. Ordinary Shares Competitors by Total Assets
Key competitors of Pulsenmore Ltd. Ordinary Shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥2.62 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
Pulsenmore Ltd. Ordinary Shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.88 | 9.28 | 26.85 |
| Quick Ratio | 7.24 | 7.65 | 26.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $71.07 Million | $117.87 Million | $173.60 Million |
Pulsenmore Ltd. Ordinary Shares - Advanced Valuation Insights
This section examines the relationship between Pulsenmore Ltd. Ordinary Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.90 |
| Latest Market Cap to Assets Ratio | 0.23 |
| Asset Growth Rate (YoY) | -28.0% |
| Total Assets | $101.85 Million |
| Market Capitalization | $23.77 Million USD |
Valuation Analysis
Below Book Valuation: The market values Pulsenmore Ltd. Ordinary Shares's assets below their book value (0.23x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Pulsenmore Ltd. Ordinary Shares's assets decreased by 28.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Pulsenmore Ltd. Ordinary Shares (2019–2025)
The table below shows the annual total assets of Pulsenmore Ltd. Ordinary Shares from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $101.85 Million | -28.03% |
| 2024-12-31 | $141.50 Million | -20.67% |
| 2023-12-31 | $178.37 Million | -22.93% |
| 2022-12-31 | $231.45 Million | +38.56% |
| 2021-12-31 | $167.04 Million | +1752.98% |
| 2020-12-31 | $9.01 Million | +42.55% |
| 2019-12-31 | $6.32 Million | -- |
About Pulsenmore Ltd. Ordinary Shares
Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products. The company was incorporated in 2014 and is based in Omer, Israel.